Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Characterized by Enhanced Endogenous Cholesterol
Irena Frankovic1, Aleksandra Zeljkovic1, Ivana Djuricic2
1Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.
Metabolic-dysfunction-associated steatotic liver disease (MASLD) is linked to increased cholesterol synthesis, as indicated by higher plasma lathosterol levels. This suggests a shift in cholesterol homeostasis in MASLD patients.
Area of Science:
- Hepatology
- Metabolic Disorders
- Lipid Metabolism
Background:
- Cholesterol accumulation is a key factor in metabolic-dysfunction-associated steatotic liver disease (MASLD) pathogenesis.
- Cholesterol homeostasis alterations in MASLD require further investigation.
Purpose of the Study:
- To investigate changes in cholesterol synthesis and absorption in MASLD patients.
- To measure plasma cholesterol precursors and phytosterols as indicators of synthesis and absorption.
Main Methods:
- Included 124 MASLD patients and 43 healthy controls.
- Measured plasma levels of cholesterol precursors (lathosterol, desmosterol) and phytosterols.
- Performed correlation and multivariate regression analyses with non-invasive hepatic steatosis indices (FLI, HSI, TyG).
Main Results:
- MASLD patients exhibited significantly higher plasma lathosterol concentrations compared to controls.
- Plasma desmosterol and phytosterol levels were comparable between MASLD patients and controls.
- Cholesterol synthesis markers (lathosterol, desmosterol) positively correlated with hepatic steatosis indices (FLI, HSI, TyG).
Conclusions:
- MASLD is associated with enhanced endogenous cholesterol synthesis.
- Cholesterol synthesis markers are significant predictors of hepatic steatosis severity in MASLD.
More Related Videos
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Inborn Errors of Metabolism
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

